Families demand full inquiry as review finds England’s maternity system failing women and babies
Bereaved mother says she is ‘absolutely not’ satisfied with reviewpublished at 08:56 BST 30 June 08:56 BST 30…
Is Medtronic plc (MDT) A Good Stock To Buy Now?
Is MDT a good stock to buy? We came across a bullish thesis on Medtronic plc on TheDividendPrince’s Substack. In…
Online retailer iHerb selects banks for US$500 million IPO this year: sources
The health and wellness company taps JPMorgan Chase, Morgan Stanley and Citigroup for the offering Published Wed, Jul…
‘Unacceptable’: Union sees red after nursing jobs cut at RVH
‘We should be increasing nurse care through safe staffing ratios, not gutting an already decimated nursing workforce,’ says…
Israel’s HIV fight falters as at least 1 in 10 carriers may not know they are infecte
Israel lacks key data on HIV testing, is falling short of international targets and still has no comprehensive…
Anthropic launches AI drug discovery program, Claude Science
CEO of Anthropic Dario Amodei attends a working lunch with G7 leaders, G7 outreach partners and global tech…
George Gresham, Health Care Union Powerhouse, Dies at 71
George Gresham, a hospital custodian who became a significant political force as the longtime president of the largest…
What Does CVS Stand For? Explained
“OK.” “A.M. and P.M.” “ZIP code.” There are many acronyms and initialisms we see and use in everyday…
The organ donation boom complicating the boundary between life and death
Emily Hoffman was walking home from lunch in the Pittsburgh neighborhood of Squirrel Hill in February 2023, when…
IBM, Verizon, Corning And A Health Care Stock On CNBC’s ‘Final Trades’ – Vertex Pharmaceuticals (NASDAQ:V
As per the recent news, Vertex Pharmaceuticals, on June 11, reported new clinical data showing that CASGEVY (exagamglogene…
Barbers bring personal grooming therapy to Kenya’s mental health hospital
NAIROBI, Kenya (AP) — At Kenya ’s largest mental health referral hospital, male patients encounter a different kind…
Evommune terminates oral drug’s development in CSU
The drug failed to show any benefit in CSU patients in a Phase IIb trial. Credit: FON’s Fasai…